These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

673 related items for PubMed ID: 30011897

  • 1. Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions.
    Savino S, Marzano C, Gandin V, Hoeschele JD, Natile G, Margiotta N.
    Int J Mol Sci; 2018 Jul 14; 19(7):. PubMed ID: 30011897
    [Abstract] [Full Text] [Related]

  • 2. Novel Pt(IV) Prodrugs Displaying Antimitochondrial Effects.
    Tabrizi L, Thompson K, Mnich K, Chintha C, Gorman AM, Morrison L, Luessing J, Lowndes NF, Dockery P, Samali A, Erxleben A.
    Mol Pharm; 2020 Aug 03; 17(8):3009-3023. PubMed ID: 32628022
    [Abstract] [Full Text] [Related]

  • 3. Dual-acting antitumor Pt(iv) prodrugs of kiteplatin with dichloroacetate axial ligands.
    Savino S, Gandin V, Hoeschele JD, Marzano C, Natile G, Margiotta N.
    Dalton Trans; 2018 May 29; 47(21):7144-7158. PubMed ID: 29766157
    [Abstract] [Full Text] [Related]

  • 4. Cytotoxicity-boosting of kiteplatin by Pt(IV) prodrugs with axial benzoate ligands.
    Margiotta N, Savino S, Marzano C, Pacifico C, Hoeschele JD, Gandin V, Natile G.
    J Inorg Biochem; 2016 Jul 29; 160():85-93. PubMed ID: 26775068
    [Abstract] [Full Text] [Related]

  • 5. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH, al-Baker S, Thai G, Khokhar AR.
    Anticancer Drug Des; 1994 Apr 29; 9(2):139-51. PubMed ID: 8166929
    [Abstract] [Full Text] [Related]

  • 6. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
    Ali MS, Khan SR, Ojima H, Guzman IY, Whitmire KH, Siddik ZH, Khokhar AR.
    J Inorg Biochem; 2005 Mar 29; 99(3):795-804. PubMed ID: 15708801
    [Abstract] [Full Text] [Related]

  • 7. Platinum(IV) Complexes of trans-1,2-diamino-4-cyclohexene: Prodrugs Affording an Oxaliplatin Analogue that Overcomes Cancer Resistance.
    Papadia P, Micoli K, Barbanente A, Ditaranto N, Hoeschele JD, Natile G, Marzano C, Gandin V, Margiotta N.
    Int J Mol Sci; 2020 Mar 27; 21(7):. PubMed ID: 32230896
    [Abstract] [Full Text] [Related]

  • 8. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
    Choi S, Vastag L, Larrabee YC, Personick ML, Schaberg KB, Fowler BJ, Sandwick RK, Rawji G.
    Inorg Chem; 2008 Feb 18; 47(4):1352-60. PubMed ID: 18220340
    [Abstract] [Full Text] [Related]

  • 9. Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(iv) prodrugs with high anti-tumor activity.
    Tan MX, Wang ZF, Qin QP, Zou BQ, Liang H.
    Dalton Trans; 2020 Feb 07; 49(5):1613-1619. PubMed ID: 31942585
    [Abstract] [Full Text] [Related]

  • 10. Improvement of Kiteplatin Efficacy by a Benzoato Pt(IV) Prodrug Suitable for Oral Administration.
    Barbanente A, Gandin V, Ceresa C, Marzano C, Ditaranto N, Hoeschele JD, Natile G, Arnesano F, Pacifico C, Intini FP, Margiotta N.
    Int J Mol Sci; 2022 Jun 25; 23(13):. PubMed ID: 35806087
    [Abstract] [Full Text] [Related]

  • 11. Cytotoxicity, cellular uptake, glutathione and DNA interactions of an antitumor large-ring Pt II chelate complex incorporating the cis-1,4-diaminocyclohexane carrier ligand.
    Kasparkova J, Suchankova T, Halamikova A, Zerzankova L, Vrana O, Margiotta N, Natile G, Brabec V.
    Biochem Pharmacol; 2010 Feb 15; 79(4):552-64. PubMed ID: 19782655
    [Abstract] [Full Text] [Related]

  • 12. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
    Kido Y, Khokhar AR, al-Baker S, Siddik ZH.
    Cancer Res; 1993 Oct 01; 53(19):4567-72. PubMed ID: 8402629
    [Abstract] [Full Text] [Related]

  • 13. Anticancer kiteplatin pyrophosphate derivatives show unexpected target selectivity for DNA.
    Kasparkova J, Kostrhunova H, Novohradsky V, Pracharova J, Curci A, Margiotta N, Natile G, Brabec V.
    Dalton Trans; 2017 Oct 24; 46(41):14139-14148. PubMed ID: 28972623
    [Abstract] [Full Text] [Related]

  • 14. Transcription inhibition by platinum-DNA cross-links in live mammalian cells.
    Ang WH, Myint M, Lippard SJ.
    J Am Chem Soc; 2010 Jun 02; 132(21):7429-35. PubMed ID: 20443565
    [Abstract] [Full Text] [Related]

  • 15. A dual-targeting hybrid platinum(IV) prodrug for enhancing efficacy.
    Xiao H, Yan L, Zhang Y, Qi R, Li W, Wang R, Liu S, Huang Y, Li Y, Jing X.
    Chem Commun (Camb); 2012 Nov 11; 48(87):10730-2. PubMed ID: 23012698
    [Abstract] [Full Text] [Related]

  • 16. cis-Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects.
    Lovejoy KS, Todd RC, Zhang S, McCormick MS, D'Aquino JA, Reardon JT, Sancar A, Giacomini KM, Lippard SJ.
    Proc Natl Acad Sci U S A; 2008 Jul 01; 105(26):8902-7. PubMed ID: 18579768
    [Abstract] [Full Text] [Related]

  • 17. Differential cytotoxicity, uptake and DNA binding of tetraplatin and analogous isomers in sensitive and resistant cancer cell lines.
    Kido Y, Khokhar AR, Siddik ZH.
    Anticancer Drugs; 1993 Apr 01; 4(2):251-8. PubMed ID: 8490203
    [Abstract] [Full Text] [Related]

  • 18. Preparation and characterization of platinum(II) and (IV) complexes of 1,3-diaminepropane and 1,4-diaminebutane: circumvention of cisplatin resistance and DNA interstrand cross-link formation in CH1cisR ovarian tumor cells.
    Alvarez-Valdés A, Pérez JM, López-Solera I, Lannegrand R, Continente JM, Amo-Ochoa P, Camazón MJ, Solans X, Font-Bardía M, Navarro-Ranninger C.
    J Med Chem; 2002 Apr 25; 45(9):1835-44. PubMed ID: 11960495
    [Abstract] [Full Text] [Related]

  • 19. Effective platinum(IV) prodrugs conjugated with lonidamine as a functional group working on the mitochondria.
    Chen H, Chen F, Hu W, Gou S.
    J Inorg Biochem; 2018 Mar 25; 180():119-128. PubMed ID: 29253663
    [Abstract] [Full Text] [Related]

  • 20. Targeting Energy Metabolism by a Platinum(IV) Prodrug as an Alternative Pathway for Cancer Suppression.
    Jin S, Guo Y, Song D, Zhu Z, Zhang Z, Sun Y, Yang T, Guo Z, Wang X.
    Inorg Chem; 2019 May 06; 58(9):6507-6516. PubMed ID: 31013065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.